Trupanion (NASDAQ:TRUP) Announces Quarterly Earnings Results, Beats Expectations By $0.02 EPS

Trupanion (NASDAQ:TRUP) posted its quarterly earnings results on Thursday. The financial services provider reported ($0.16) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.18) by $0.02, Briefing.com reports. The business had revenue of $306.12 million for the quarter, compared to analyst estimates of $300.51 million. Trupanion had a negative return on equity of 9.10% and a negative net margin of 2.31%. Trupanion’s revenue for the quarter was up 19.4% compared to the same quarter last year. During the same period last year, the company earned ($0.60) EPS.

Trupanion Stock Down 16.5 %

Shares of TRUP traded down $3.93 on Friday, reaching $19.85. The stock had a trading volume of 2,330,524 shares, compared to its average volume of 553,707. The firm has a market capitalization of $833.50 million, a price-to-earnings ratio of -31.02 and a beta of 1.76. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.63 and a current ratio of 1.63. Trupanion has a 12-month low of $18.45 and a 12-month high of $36.82. The company has a 50-day simple moving average of $25.67 and a 200-day simple moving average of $26.77.

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on TRUP shares. Canaccord Genuity Group lowered their price objective on shares of Trupanion from $40.00 to $34.00 and set a “buy” rating for the company in a research note on Friday. Stifel Nicolaus increased their price objective on Trupanion from $25.00 to $28.00 and gave the stock a “hold” rating in a report on Friday, February 16th. Piper Sandler dropped their price objective on Trupanion from $28.00 to $22.00 and set a “neutral” rating for the company in a report on Friday. Finally, Evercore ISI dropped their price objective on Trupanion from $35.00 to $31.00 and set an “outperform” rating for the company in a report on Tuesday, February 20th. Four investment analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $32.33.

About Trupanion

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.